Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.
- DOI
- 10.3390/bioengineering9080392
- Published
- 2022 Aug 15
- Container
- Bioengineering (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/bioengineering9080392,
title = {Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.},
author = {Ghasemzad M and Hashemi M and Lavasani ZM and Hossein-Khannazer N and Bakhshandeh H and Gramignoli R and Keshavarz Alikhani H and Najimi M and Nikeghbalian S and Vosough M},
year = {2022},
journal = {Bioengineering (Basel, Switzerland)},
doi = {10.3390/bioengineering9080392},
url = {https://doi.org/10.3390/bioengineering9080392}
}RIS
TY - JOUR TI - Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders. AU - Ghasemzad M AU - Hashemi M AU - Lavasani ZM AU - Hossein-Khannazer N AU - Bakhshandeh H AU - Gramignoli R AU - Keshavarz Alikhani H AU - Najimi M AU - Nikeghbalian S AU - Vosough M PY - 2022 JO - Bioengineering (Basel, Switzerland) DO - 10.3390/bioengineering9080392 UR - https://doi.org/10.3390/bioengineering9080392 ER -
APA
M, G., M, H., ZM, L., N, H., H, B., R, G., H, K. A., M, N., S, N., & M, V. (2022). Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders.. Bioengineering (Basel, Switzerland). https://doi.org/10.3390/bioengineering9080392
Source records
- pubmed · retrieved 2026-09-27T13:12:37.745Z